BMX
Basic information
Region (hg38): X:15464246-15556529
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the BMX gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 14 | 17 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 1 | |||||
Total | 0 | 0 | 14 | 3 | 4 |
Variants in BMX
This is a list of pathogenic ClinVar variants found in the BMX region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
X-15479812-G-T | not specified | Uncertain significance (Jun 07, 2024) | ||
X-15479820-A-G | not specified | Uncertain significance (Jun 07, 2024) | ||
X-15511457-T-A | Benign (Feb 08, 2018) | |||
X-15516129-C-T | not specified | Uncertain significance (Aug 18, 2021) | ||
X-15516168-G-T | not specified | Uncertain significance (Feb 12, 2024) | ||
X-15516211-G-A | not specified | Uncertain significance (Dec 28, 2022) | ||
X-15517947-C-T | not specified | Uncertain significance (Dec 17, 2023) | ||
X-15517955-G-A | not specified | Uncertain significance (Feb 22, 2023) | ||
X-15522377-A-G | not specified | Likely benign (Mar 01, 2023) | ||
X-15522470-G-C | not specified | Likely benign (Nov 07, 2022) | ||
X-15522475-G-A | not specified | Uncertain significance (Jan 16, 2024) | ||
X-15522476-C-T | Benign (Dec 19, 2017) | |||
X-15529992-T-G | not specified | Uncertain significance (May 24, 2023) | ||
X-15536403-C-T | not specified | Uncertain significance (May 13, 2024) | ||
X-15537153-A-G | Likely benign (Jan 01, 2023) | |||
X-15541995-C-G | not specified | Uncertain significance (Sep 01, 2021) | ||
X-15542086-A-T | not specified | Uncertain significance (Feb 22, 2023) | ||
X-15542189-C-T | Benign (Mar 29, 2018) | |||
X-15542204-C-A | Likely benign (Apr 01, 2023) | |||
X-15546837-G-A | not specified | Uncertain significance (Sep 15, 2021) | ||
X-15546837-G-C | not specified | Uncertain significance (Dec 20, 2023) | ||
X-15549831-G-C | Benign (May 18, 2018) | |||
X-15549906-T-C | not specified | Uncertain significance (Mar 07, 2024) | ||
X-15549941-C-T | not specified | Uncertain significance (Aug 19, 2023) | ||
X-15549995-G-A | not specified | Uncertain significance (Nov 12, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
BMX | protein_coding | protein_coding | ENST00000357607 | 18 | 92284 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00667 | 0.993 | 125711 | 12 | 7 | 125730 | 0.0000756 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.991 | 197 | 240 | 0.820 | 0.0000174 | 4459 |
Missense in Polyphen | 70 | 107.39 | 0.65183 | 2029 | ||
Synonymous | -0.218 | 93 | 90.4 | 1.03 | 0.00000683 | 1182 |
Loss of Function | 3.31 | 9 | 27.9 | 0.323 | 0.00000183 | 539 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000195 | 0.000161 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000363 | 0.000272 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000529 | 0.0000352 |
Middle Eastern | 0.000363 | 0.000272 |
South Asian | 0.000322 | 0.000196 |
Other | 0.000225 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Non-receptor tyrosine kinase that plays central but diverse modulatory roles in various signaling processes involved in the regulation of actin reorganization, cell migration, cell proliferation and survival, cell adhesion, and apoptosis. Participates in signal transduction stimulated by growth factor receptors, cytokine receptors, G-protein coupled receptors, antigen receptors and integrins. Induces tyrosine phosphorylation of BCAR1 in response to integrin regulation. Activation of BMX by integrins is mediated by PTK2/FAK1, a key mediator of integrin signaling events leading to the regulation of actin cytoskeleton and cell motility. Plays a critical role in TNF-induced angiogenesis, and implicated in the signaling of TEK and FLT1 receptors, 2 important receptor families essential for angiogenesis. Required for the phosphorylation and activation of STAT3, a transcription factor involved in cell differentiation. Also involved in interleukin-6 (IL6) induced differentiation. Plays also a role in programming adaptive cytoprotection against extracellular stress in different cell systems, salivary epithelial cells, brain endothelial cells, and dermal fibroblasts. May be involved in regulation of endocytosis through its interaction with an endosomal protein RUFY1. May also play a role in the growth and differentiation of hematopoietic cells; as well as in signal transduction in endocardial and arterial endothelial cells. {ECO:0000269|PubMed:10688651, ECO:0000269|PubMed:11331870, ECO:0000269|PubMed:12370298, ECO:0000269|PubMed:12832404, ECO:0000269|PubMed:15788485, ECO:0000269|PubMed:18292575, ECO:0000269|PubMed:9520419}.;
- Pathway
- Angiogenesis overview;Metabolism of lipids;Apoptotic cleavage of cellular proteins;Metabolism;Apoptotic execution phase;Apoptosis;Programmed Cell Death;Synthesis of PIPs at the plasma membrane;Angiopoietin receptor Tie2-mediated signaling;PI Metabolism;Phospholipid metabolism;IL6;Signaling events mediated by focal adhesion kinase
(Consensus)
Recessive Scores
- pRec
- 0.163
Intolerance Scores
- loftool
- 0.320
- rvis_EVS
- -0.12
- rvis_percentile_EVS
- 45.13
Haploinsufficiency Scores
- pHI
- 0.480
- hipred
- Y
- hipred_score
- 0.736
- ghis
- 0.505
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.983
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Bmx
- Phenotype
- skeleton phenotype; normal phenotype; immune system phenotype;
Gene ontology
- Biological process
- adaptive immune response;protein phosphorylation;phosphatidylinositol biosynthetic process;apoptotic process;cell adhesion;signal transduction;mesoderm development;intracellular signal transduction;peptidyl-tyrosine autophosphorylation;protein autophosphorylation;B cell receptor signaling pathway
- Cellular component
- nucleoplasm;cytosol;plasma membrane;ruffle membrane
- Molecular function
- protein tyrosine kinase activity;non-membrane spanning protein tyrosine kinase activity;protein binding;ATP binding;metal ion binding